• Orchestra BioMed director Aryeh Jason bought 665 shares of common stock at a weighted average price of $3.75.
• Direct holdings rose to 118,118 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orchestra Biomed Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-064136), on May 20, 2026, and is solely responsible for the information contained therein.